Article Text
Abstract
Background Gabapentin is an effective therapeutic alternative for chronic low back pain, indicated in several guidelines for treating neuropathic pain as first-line medication. This study aimed to describe the pharmacodynamics of gabapentin in the central nervous system of patients with chronic low back pain (CLBP) by using single-photon emission CT (SPECT) with [99mTc]Tc-ECD.
Methods We selected 13 patients with CLBP due to lumbar disc herniation. They underwent SPECT before and after using gabapentin, compared with a SPECT database of healthy volunteers. A second analysis compared regional cerebral blood flow (rCBF) changes between responders and non-responders to gabapentin and the healthy controls.
Results The mean age of patients was 41 years, and the mean pain intensity was 5.92 points, measured by the Numeric Rating Scale. After using gabapentin, SPECT showed an increase of rCBF in the bilateral anterior cingulate gyrus and a decrease of rCBF in periaqueductal gray matter. Non-responder patients with gabapentin showed a post-treatment decrease of rCBF in the paracentral lobule of the brain.
Conclusions A lack of improvement in some patients with gabapentin may be associated with an activated affective circuit of pain, evidenced by the increase of rCBF of the anterior cingulate cortex. A maladaptive brain state in chronic pain can explain the decrease of rCBF in the default mode network structures. Gabapentin acts directly or indirectly on neurons of periaqueductal gray substance by increasing the pain threshold and decreasing the rCBF of this structure.
- Back Pain
- CHRONIC PAIN
- Pharmacology
Data availability statement
All data relevant to the study are included in the article or uploaded as online supplemental information.
Statistics from Altmetric.com
Data availability statement
All data relevant to the study are included in the article or uploaded as online supplemental information.
Footnotes
Contributors PP is the guarantor of this article. PP, FD, LW-A and ODP contributed to the study conception and design. ACT and LA-S contributed to the data processing. PP, FD, ENL, EBC, VLL and LW-A contributed to the data presentation and writing of the manuscript. PP and LW-A contributed to the figures. All authors read and approved the final manuscript.
Funding The authors gratefully acknowledge financial support from: (A) Grant #049/2013 (AUXPE No. 2880/2013) from CAPES / NUFFIC, Brazil Netherlands International Cooperation; (B) Grant #2015/50089-3 and Grant #2021/12671-3, São Paulo Research Foundation (FAPESP).
Competing interests None declared.
Provenance and peer review Not commissioned; externally peer reviewed.
© American Society of Regional Anesthesia & Pain Medicine 2023. No commercial re-use. See rights and permissions. Published by BMJ.